NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT02429804 · TERMINATED

Trial details

NCT number: NCT02429804
Sponsor: Stanford University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Malignant Neoplasm in the Bone Metastatic Prostate Carcinoma

Start date: 2015-04-01
Primary completion: 2017-05-15
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.